IRIS
DIELLA, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.140
AS - Asia 725
EU - Europa 709
SA - Sud America 158
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 38
OC - Oceania 2
Totale 2.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.088
SG - Singapore 351
IT - Italia 296
BR - Brasile 109
CN - Cina 100
DE - Germania 100
HK - Hong Kong 83
RU - Federazione Russa 78
VN - Vietnam 59
FR - Francia 57
GB - Regno Unito 34
FI - Finlandia 33
BD - Bangladesh 32
SE - Svezia 31
CA - Canada 25
NL - Olanda 19
MX - Messico 18
CI - Costa d'Avorio 17
ID - Indonesia 15
AR - Argentina 14
ES - Italia 12
IN - India 12
PL - Polonia 12
CO - Colombia 11
PH - Filippine 11
IQ - Iraq 9
LT - Lituania 9
PK - Pakistan 9
TR - Turchia 9
VE - Venezuela 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 7
EC - Ecuador 6
UA - Ucraina 6
JO - Giordania 5
MA - Marocco 5
SA - Arabia Saudita 5
CL - Cile 4
AT - Austria 3
JP - Giappone 3
NP - Nepal 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
HN - Honduras 2
IE - Irlanda 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
BE - Belgio 1
BY - Bielorussia 1
BZ - Belize 1
EG - Egitto 1
ET - Etiopia 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
MZ - Mozambico 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 2.772
Salva come PNG Salva come JPEG
Città #
Singapore 226
Ashburn 185
San Jose 147
Hong Kong 82
Milan 69
Council Bluffs 58
Beijing 49
Rome 47
Los Angeles 45
New York 42
Munich 40
Falkenstein 29
Columbus 28
Lauterbourg 28
Boardman 26
Nyköping 24
Helsinki 23
Santa Clara 22
Chandler 21
Buffalo 20
Dallas 20
Bari 19
Abidjan 17
Frankfurt am Main 17
Chicago 16
Ho Chi Minh City 16
São Paulo 14
Phoenix 13
Brooklyn 11
London 11
Hanoi 10
Turku 10
Atlanta 9
Jakarta 9
Moscow 9
Toronto 9
Warsaw 9
Mexico City 8
Brno 7
Montreal 7
Stockholm 7
Düsseldorf 6
Orem 6
Rio de Janeiro 6
Tampa 6
Detroit 5
Figino 5
Medellín 5
Nuremberg 5
Salt Lake City 5
San Diego 5
Turin 5
Amman 4
Brasília 4
City of London 4
Curitiba 4
Da Nang 4
Denver 4
Houston 4
Johannesburg 4
Marseille 4
Monza 4
Naples 4
Palermo 4
Poplar 4
San Francisco 4
Seattle 4
Bogotá 3
Bologna 3
Caracas 3
Charlotte 3
Chennai 3
Contagem 3
Fairfield 3
Haiphong 3
Lahore 3
Manila 3
Querétaro 3
Redondo Beach 3
Rosà 3
Tokyo 3
Wilmington 3
Woodbridge 3
Wroclaw 3
Angri 2
Asunción 2
Aversa 2
Avon 2
Baghdad 2
Barletta 2
Boston 2
Bratislava 2
Bắc Ninh 2
Cape Town 2
Dublin 2
Elk Grove Village 2
Guangzhou 2
Guarulhos 2
Guayaquil 2
Istanbul 2
Totale 1.661
Salva come PNG Salva come JPEG
Nome #
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 174
Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives 150
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study 144
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 139
A Challenging Case of Visceral Leishmaniasis 138
Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review 125
Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii: A Real Life, Prospective, Observational, Single-Center Study 121
Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center "Proof-of-Concept" Study 118
Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study 108
Analysis of Italian requests for compensation in cases of responsibility for healthcare-related infections: A retrospective study 103
Prompt and Appropriate Antimicrobial Therapy Improves Outcomes of NDM-Producing and KPC-Producing Klebsiella pneumoniae Bloodstream Infections in Patients Hospitalized for COVID-19: A Comparative Retrospective Case-Series 102
Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae: A Retrospective Case Series and Literature Review 101
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections 96
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study 92
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study 91
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 91
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study 90
Thoracic aorta graft infection by avibactam-resistant KPC-producing K. pneumoniae treated with meropenem/vaborbactam: a case report and literature review 89
Impact of a Pro-Active Infectious Disease Consultation on the Management of a Multidrug-Resistant Organisms Outbreak in a COVID-19 Hospital: A Three-Months Quasi-Experimental Study 89
Oral anti‐viral therapy for early COVID‐19 infection in patients with haematological malignancies: A multicentre prospective cohort 83
Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections 81
First-line combination therapy with fifth generation cephalosporins plus daptomycin compared to other-antimicrobial-regimens for methicillin-resistant Staphylococcus aureus bacteraemia: a multicenter retrospective cohort study 72
Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort study 71
Incidence and predictors of infections in patients with advanced non‐small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric retrospective cohort study 71
Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional study 69
Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients 67
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 58
Guinea Worm Disease: A Neglected Diseases on the Verge of Eradication 47
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study 45
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 39
Anti–Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a “Hit Hard and Fast” Strategy Improve Outcomes? 10
Is early combination therapy associated with lower risk of respiratory failure in severely immunocompromised hosts with COVID-19? a target trial emulation study from the omicron-dominant era 5
Totale 2.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 1 0 2 2 2 1 6
2022/202386 2 8 2 3 14 13 3 18 12 2 1 8
2023/2024116 10 22 3 13 13 25 0 8 1 1 3 17
2024/2025634 28 16 6 28 20 55 83 76 26 68 78 150
2025/20261.750 209 61 89 186 216 124 169 65 204 174 55 198
2026/2027260 82 142 36 0 0 0 0 0 0 0 0 0
Totale 2.879